AlphAIAlphAI — Financial news for AI agents
SEC EDGARMAY 302 min read$THC

KERREY J ROBERT sold $125K of THC

KERREY J ROBERT sold 713 shares of TENET HEALTHCARE CORP (THC) at $175.13 ($0.12M total) on 2026-05-28.

Original reporting
SEC EDGAR · KERREY J ROBERT
Published May 30, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 30, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$THC
Neutral
low confidence
Mentioned
$THC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCNeutralLow
01

Why it matters

The disclosure provides incremental information about insider behavior but does not include new company performance, guidance, or legal/contract developments.

02

Market read

Traders may briefly reassess sentiment around THC due to insider selling, but the event lacks fundamental linkage in the filing.

03

What to watch

No 10b5-1 plan is indicated, so traders may over-interpret; also the disclosed sale size is relatively small versus typical institutional flows.

Relevance 6/10Novelty 6/10Timing: Filed 2026-05-29 for a sale executed 2026-05-28

Background

SEC Form 4 reports insider transactions by directors/officers/10%-owners; markets often treat these as sentiment signals rather than fundamental drivers.

Company-level read

Ticker impact

$THCNeutralLow confidence
Context

Tenet Healthcare director Kerrey J. Robert sold 713 shares in an open-market transaction for ~$124.9K at $175.13 on 2026-05-28.

Expected impact

Low near-term impact; any move is likely limited unless accompanied by other news.

Evidence & confidence

This is a routine Form 4 insider sale with no 10b5-1 plan stated; size is modest and there is no accompanying operational/financial update.

Market effects

Sector

Minimal; single-company insider sale typically does not reset sector expectations.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Director sales can be driven by diversification, taxes, or scheduled liquidity needs rather than bearish fundamentals.

Key entities

  • issuer
    Tenet Healthcare Corp

    Subject of the Form 4 insider sale by a director.

  • insider
    Kerrey J. Robert

    Director who sold 713 shares of THC for ~$124.9K.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

THC insider trading history →

Related articles

SEP 9
$THCMedAI 8/10

What Tenet Healthcare (THC)'s $2b Debt Refinance Means For Shareholders

Tenet Healthcare (THC) priced a $2.0 billion private placement of 6.250% senior notes due 2034, upsized from $1.5 billion, to refinance existing 2027 and 2028 debt. The refinancing replaces secured and partly secured borrowings with unsecured notes, altering the company's debt structure. Investors focus on execution, pricing, and free cash flow, with high debt and earnings declines noted as risks.

simplywall.st2 min
SEP 9
$THCMedAI 8/10

Tenet Healthcare at Wells Fargo conference: high-acuity push deepens

Tenet Healthcare (THC) presented at the Wells Fargo Healthcare Conference, outlining a strategy focused on high-acuity care, capital spending, and cost control. The company raised full-year guidance, citing volume growth and cost discipline. Shares are near their 52-week high at $268.82, up over 30% year-to-date. Tenet expects continued pressure in some payer channels and near-term earnings drag from Conifer's transition. Management plans to invest in complex procedures and maintain capital spen

uk.investing.com2 min